Future Medicine Co Ltd
341170
Company Profile
Business description
Future Medicine Co Ltd is a drug development company. It engages in the development of new drug candidates for anti-inflammatory/anti-fibrosis of non-alcoholic hepatitis (NASH) drugs, oral glaucoma treatments, and chronic kidney disease treatments, as well as targeted and Immuno cancer drugs.
Contact
54 changup-ro
616, 2 Techno Valley Enterprise Growth Center
Gyeonggi-do, Siheung-dong, LH Pangyo-je
Seongnam-si13449
KORT: +82 234293473
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
8
Stocks News & Analysis
stocks
Overvalued ASX share as market underestimates downside risks
Growth outlook solid, but upside more than priced in.
stocks
New production imminent for undervalued ASX gas play
LNG project receives first commissioning gas.
stocks
Going into earnings, is Tesla stock a buy, a sell, or fairly valued?
Awaiting more info on robotaxis and lower cost models, here’s what we think of Tesla stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,324.60 | 40.80 | 0.44% |
| CAC 40 | 8,201.98 | 27.78 | 0.34% |
| DAX 40 | 24,226.46 | 395.47 | 1.66% |
| Dow JONES (US) | 46,469.36 | 278.75 | 0.60% |
| FTSE 100 | 9,405.20 | 50.63 | 0.54% |
| HKSE | 25,858.83 | 611.73 | 2.42% |
| NASDAQ | 22,915.18 | 235.21 | 1.04% |
| Nikkei 225 | 49,185.50 | 1,603.35 | 3.37% |
| NZX 50 Index | 13,344.96 | 55.75 | 0.42% |
| S&P 500 | 6,715.45 | 51.44 | 0.77% |
| S&P/ASX 200 | 9,031.90 | 43.70 | 0.49% |
| SSE Composite Index | 3,863.89 | 24.14 | 0.63% |